Founded in 2023, BacAlt Biosciences operates in Clean Tech offering value-added biopolymers derived from post-harvest waste. The company focuses on applications in textile, skincare, wound care, and a...
Funding stage:
Pre-Seed
Last funding:
10/09/2025
Total funding:
$2.00 Mn+
Revenue:
Investors
Employee count:
12
Last 90d
12
Last 90d
BacAlt Biosciences: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders3
Latest Filing Date23 Dec 2025- Funding Events1
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of BacAlt Biosciences
As of 24 December 2025, BacAlt Biosciences's equity is held by 3 shareholders, with the top three being Shruti Ketan Kutmutia, Pranav Girijavallabhan Nair, and Avaana Sustainability Fund.
Shruti Ketan Kutmutia holds the largest stake in BacAlt Biosciences at 62.8% as of 24 December 2025.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links